Bluejay Diagnostics, Inc. (BJDX) - Dilution Analysis

10-Q filing | 1.0M shares outstanding

8-K filing: Stock split 1-for-4 | Outstanding: 1,814,133 → 708,533

10-Q filing | 1.8M shares outstanding

S-3 filing: This prospectus relates to the resale of up to 6,930,000 shares of common stock by the selling stockholders.

8-K filing: Bluejay Diagnostics, Inc. completed a private placement on October 10, 2025, issuing 175,000 shares of common stock, pre-funded warrants to purchase 2,075,000 shares of common stock, and Series F warrants to purchase up to 4,500,000 shares of common stock, with gross proceeds of approximately $4.0 million. ($4.0M proceeds)

10-Q filing | 1.5M shares outstanding

S-3 filing: This is an S-3 filing for the resale of up to 1,085,106 shares of common stock issuable upon the exercise of warrants held by selling stockholders.

10-K filing | 0.6M shares outstanding

8-K filing: Stock split 1-for-50 | Outstanding: 26,883,971 → 552,854

10-Q filing | 26.9M shares outstanding

8-K filing: Amendment to the company's certificate of incorporation to increase the number of authorized shares of Common Stock from 50,000,000 to 250,000,000, 6.6 million shares of Common Stock were issued upon the exercise of Class D warrants, and a further 14.9 million shares of Common Stock were issuable upon the future exercise of Class D warrants. ($0.0M proceeds)

10-Q filing | 6.3M shares outstanding

S-1/A filing: Bluejay Diagnostics, Inc. is offering 2,906,977 units, each consisting of one share of common stock or one prefunded warrant to purchase one share of common stock, two Class C warrants each to purchase one share of common stock and one Class D warrant to purchase such number of shares of common stock as determined in the Class D Warrant, on a firm commitment, underwritten basis.

8-K filing: Stock split 1-for-8 | Outstanding: 4,511,756 → 563,969

S-1 filing: Bluejay Diagnostics, Inc. is offering units, each consisting of one share of common stock or one prefunded warrant, two Class C warrants, and one Class D warrant in a firm commitment, underwritten offering.

8-K filing: Bluejay Diagnostics, Inc. entered into a Note Purchase Agreement and a Securities Purchase Agreement to issue senior secured notes and 580,308 shares of common stock for a total of $2,000,000 in cash. ($1.0M proceeds)

10-Q filing | 2.9M shares outstanding

10-K filing | 2.7M shares outstanding

S-1/A filing: BLUEJAY DIAGNOSTICS, INC. is offering up to 2,026,958 shares of common stock, prefunded warrants to purchase up to 2,026,958 shares of common stock, common warrants to purchase up to 2,026,958 shares of common stock, 2,026,958 shares of common stock underlying prefunded warrants and common warrants, placement agent warrants to purchase up to 141,887 shares of common stock and 141,887 shares of common stock underlying the placement agent warrants.

S-1/A filing: Bluejay Diagnostics, Inc. is offering up to 2,026,958 shares of common stock, together with warrants to purchase up to 2,026,958 shares of common stock, and prefunded warrants to purchase up to an aggregate of 2,026,958 shares of common stock.

S-1 filing: BLUEJAY DIAGNOSTICS, INC. is offering shares of common stock, together with warrants, and prefunded warrants.

10-Q filing | 1.2M shares outstanding

10-Q filing | 1.0M shares outstanding

8-K filing: Stock split 1-for-20 | Outstanding: 20,375,092 → 1,023,344

S-3 filing: The company is filing an S-3 to register the offering of up to $25,000,000 in the aggregate of debt securities, common stock, preferred stock, depository shares, rights and units.

10-Q filing | 20.4M shares outstanding

10-K filing | 20.2M shares outstanding

10-Q filing | 20.2M shares outstanding

10-Q filing | 20.2M shares outstanding

10-Q filing | 20.2M shares outstanding

10-K filing | 20.2M shares outstanding

10-Q filing | 19.5M shares outstanding

8-K filing: Bluejay Diagnostics, Inc. completed an initial public offering of 2,160,000 units at $10.00 per unit, with each unit consisting of one share of common stock, one Class A warrant, and one Class B warrant, and the underwriter partially exercised its option to purchase an additional 324,000 Class A warrants and 324,000 Class B warrants. ($21.6M proceeds)

S-1/A filing: This is an S-1/A filing for a combination offering of common stock, Series E Convertible Preferred Stock, Class A Warrants, and Class B Warrants. The proposed offering includes 4,500,000 shares of common stock at an assumed price of $10.00 per share.

S-1/A filing: This is an S-1/A filing from 2021-10-25 related to an offering of common stock, Series E Convertible Preferred Stock, Class A Warrants, and Class B Warrants. The maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any Series E Convertible Preferred Stock offered and sold.

S-1 filing: An S-1 filing dated 2021-10-04 for a combination offering including common stock, Series E Convertible Preferred Stock, Class A Warrants, and Class B Warrants.